Literature DB >> 20130218

Importance of cytokines in murine allergic airway disease and human asthma.

Fred D Finkelman1, Simon P Hogan, Gurjit K Khurana Hershey, Marc E Rothenberg, Marsha Wills-Karp.   

Abstract

Asthma is a common, disabling inflammatory respiratory disease that has increased in frequency and severity in developed nations. We review studies of murine allergic airway disease (MAAD) and human asthma that evaluate the importance of Th2 cytokines, Th2 response-promoting cytokines, IL-17, and proinflammatory and anti-inflammatory cytokines in MAAD and human asthma. We discuss murine studies that directly stimulate airways with specific cytokines or delete, inactivate, neutralize, or block specific cytokines or their receptors, as well as controversial issues including the roles of IL-5, IL-17, and IL-13Ralpha2 in MAAD and IL-4Ralpha expression by specific cell types. Studies of human asthmatic cytokine gene and protein expression, linkage of cytokine polymorphisms to asthma, cytokine responses to allergen stimulation, and clinical responses to cytokine antagonists are discussed as well. Results of these analyses establish the importance of specific cytokines in MAAD and human asthma and have therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20130218      PMCID: PMC4122090          DOI: 10.4049/jimmunol.0902185

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  247 in total

1.  Role of IL-4, IL-13, and STAT6 in inflammation-induced hypercontractility of murine smooth muscle cells.

Authors:  Hirotada Akiho; Patricia Blennerhassett; Yikang Deng; Stephen M Collins
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-02       Impact factor: 4.052

2.  The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells.

Authors:  Rajeev Venkayya; Maggie Lam; Madeleine Willkom; Gabriele Grünig; David B Corry; David J Erle
Journal:  Am J Respir Cell Mol Biol       Date:  2002-02       Impact factor: 6.914

3.  TGFbeta1 allele association with asthma severity.

Authors:  L J Pulleyn; R Newton; I M Adcock; P J Barnes
Journal:  Hum Genet       Date:  2001-10-27       Impact factor: 4.132

4.  Evidence for systemic rather than pulmonary effects of interleukin-5 administration in asthma.

Authors:  E L van Rensen; R G Stirling; J Scheerens; K Staples; P J Sterk; P J Barnes; K F Chung
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

5.  Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet.

Authors:  Susetta Finotto; Markus F Neurath; Jonathan N Glickman; Shixin Qin; Hans A Lehr; Francis H Y Green; Kate Ackerman; Kathleen Haley; Peter R Galle; Susanne J Szabo; Jeffrey M Drazen; George T De Sanctis; Laurie H Glimcher
Journal:  Science       Date:  2002-01-11       Impact factor: 47.728

6.  Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology.

Authors:  Ulla-Angela Temann; Prabir Ray; Richard A Flavell
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

7.  CD4(+) T cell-dependent airway mucus production occurs in response to IL-5 expression in lung.

Authors:  J Paul Justice; J Crosby; M T Borchers; A Tomkinson; J J Lee; N A Lee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-05       Impact factor: 5.464

8.  Haplotypes of the 5' region of the IL-4 gene and SNPs in the intergene sequence between the IL-4 and IL-13 genes are associated with atopic asthma.

Authors:  E Noguchi; Y Nukaga-Nishio; Z Jian; Y Yokouchi; M Kamioka; K Yamakawa-Kobayashi; H Hamaguchi; A Matsui; M Shibasaki; T Arinami
Journal:  Hum Immunol       Date:  2001-11       Impact factor: 2.850

9.  Relation between tumour necrosis factor polymorphism TNFalpha-308 and risk of asthma.

Authors:  John S Witte; Lyle J Palmer; Richard D O'Connor; Penelope J Hopkins; Jeff M Hall
Journal:  Eur J Hum Genet       Date:  2002-01       Impact factor: 4.246

10.  The absence of interleukin 9 does not affect the development of allergen-induced pulmonary inflammation nor airway hyperreactivity.

Authors:  Sarah J McMillan; Benjamin Bishop; Michael J Townsend; Andrew N McKenzie; Clare M Lloyd
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

View more
  112 in total

Review 1.  Age-related changes in immune function: effect on airway inflammation.

Authors:  Paula J Busse; Sameer K Mathur
Journal:  J Allergy Clin Immunol       Date:  2010-10       Impact factor: 10.793

2.  CARMA1 is necessary for optimal T cell responses in a murine model of allergic asthma.

Authors:  Ravisankar A Ramadas; Marly I Roche; James J Moon; Thomas Ludwig; Ramnik J Xavier; Benjamin D Medoff
Journal:  J Immunol       Date:  2011-11-09       Impact factor: 5.422

3.  Development of a human IgG4 bispecific antibody for dual targeting of interleukin-4 (IL-4) and interleukin-13 (IL-13) cytokines.

Authors:  Christoph Spiess; Jack Bevers; Janet Jackman; Nancy Chiang; Gerald Nakamura; Michael Dillon; Hongbin Liu; Patricia Molina; J Michael Elliott; Whitney Shatz; Justin M Scheer; Glen Giese; Josefine Persson; Yin Zhang; Mark S Dennis; James Giulianotti; Prateek Gupta; Dorothea Reilly; Enzo Palma; Jianyong Wang; Eric Stefanich; Heleen Scheerens; Germaine Fuh; Lawren C Wu
Journal:  J Biol Chem       Date:  2013-07-23       Impact factor: 5.157

Review 4.  Complement: a key system for immune surveillance and homeostasis.

Authors:  Daniel Ricklin; George Hajishengallis; Kun Yang; John D Lambris
Journal:  Nat Immunol       Date:  2010-08-19       Impact factor: 25.606

Review 5.  CD4+ T-cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm.

Authors:  Kiyoshi Hirahara; Toshinori Nakayama
Journal:  Int Immunol       Date:  2016-02-12       Impact factor: 4.823

6.  Adenovirus-mediated interleukin-35 gene transfer suppresses allergic airway inflammation in a murine model of asthma.

Authors:  Yan Li; Xiuhe Pan; Xiao Peng; Shubo Li; Yanchun Zhou; Xiaoxuan Zheng; Mingcai Li
Journal:  Inflamm Res       Date:  2015-08-30       Impact factor: 4.575

7.  The protective role of TLR6 in a mouse model of asthma is mediated by IL-23 and IL-17A.

Authors:  Ana Paula Moreira; Karen A Cavassani; Ugur B Ismailoglu; Rikki Hullinger; Michael P Dunleavy; Darryl A Knight; Steven L Kunkel; Satoshi Uematsu; Shizuo Akira; Cory M Hogaboam
Journal:  J Clin Invest       Date:  2011-10-17       Impact factor: 14.808

8.  Role of growth arrest-specific gene 6 in the development of fungal allergic airway disease in mice.

Authors:  Takehiko Shibata; Ugur Burcin Ismailoglu; Nicolai A Kittan; Ana Paula Moreira; Ana Lucia Coelho; Geoffrey L Chupp; Steven L Kunkel; Nicholas W Lukacs; Cory M Hogaboam
Journal:  Am J Respir Cell Mol Biol       Date:  2014-11       Impact factor: 6.914

Review 9.  The potential for genetically altered microglia to influence glioma treatment.

Authors:  W Li; R M D Holsinger; C A Kruse; A Flügel; M B Graeber
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-09       Impact factor: 4.388

10.  Combined administration of anti-IL-13 and anti-IL-17A at individually sub-therapeutic doses limits asthma-like symptoms in a mouse model of Th2/Th17 high asthma.

Authors:  Dasom Kim; Jaclyn W McAlees; Lindsay J Bischoff; Davinder Kaur; Lauren K Houshel; Jerilyn Gray; Julie Hargis; Xenia Davis; Paul L Dudas; Hitesh Deshmukh; Ian P Lewkowich
Journal:  Clin Exp Allergy       Date:  2018-11-29       Impact factor: 5.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.